Rime Benmalek1*, Zeine El Abasse1, Anas Maaroufi1 and Rachida Habbal1
Coronavirus disease-2019 (COVID-19) is known to predispose patients to thrombotic disease, especially venous thromboembolism. However, arterial thrombosis is exceptionally described and can be associated with other additional risk factors increasing the risk for thromboembolism, making the management of these patients challenging.